M F Drummond1. Show Affiliations » 1. University of York, United Kingdom.
Abstract
Mesh: See more » AustraliaCost-Benefit AnalysisCosts and Cost AnalysisDrug CostsDrug Industry/economicsForecastingGovernmentGuidelines as TopicInsurance, Pharmaceutical Services/legislation & jurisprudenceInsurance, Pharmaceutical Services/standards
Year: 1992 PMID: 1483639 DOI: 10.1377/hlthaff.11.4.191
Source DB: PubMed Journal: Health Aff (Millwood) ISSN: 0278-2715 Impact factor: 6.301